PainReform (PRFX) Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
TEL AVIV, Israel, May 15, 2023 (GLOBE NEWSWIRE) PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established
PainReform Provides Business Update for the First Quarter of 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PainReform Ltd. (NASDAQ:PRFX – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 67,400 shares, a growth of 28.4% from the March 15th total of 52,500 shares. Based on an average daily volume of 276,000 shares, the days-to-cover […]